Authors: STAUDERMAN KA MAHAFFY LS AKONG M VELICELEBI G CHAVEZNORIEGA LE CRONA JH JOHNSON EC ELLIOTT KJ GILLESPIE A REID RT ADAMS P HARPOLD MM COREYNAEVE J

Citation: Ka. Stauderman et al., CHARACTERIZATION OF HUMAN RECOMBINANT NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT COMBINATIONS ALPHA-2-BETA-4, ALPHA-3-BETA-4 AND ALPHA-4-BETA-4 STABLY EXPRESSED IN HEK293 CELLS, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 777-789

Authors: SACAAN AI REID RT SANTORI EM ADAMS P CORREA LD MAHAFFY LS BLEICHER L COSFORD NDP STAUDERMAN KA MCDONALD IA RAO TS LLOYD GK

Citation: Ai. Sacaan et al., PHARMACOLOGICAL CHARACTERIZATION OF SIB-1765F - A NOVEL CHOLINERGIC ION-CHANNEL AGONIST, The Journal of pharmacology and experimental therapeutics, 280(1), 1997, pp. 373-383

Authors: COSFORD NDP BLEICHER L HERBAUT A MCCALLUM JS VERNIER JM DAWSON H WHITTEN JP ADAMS P CHAVEZNORIEGA L CORREA LD CRONA JH MAHAFFY LS MENZAGHI F RAO TS REID R SACAAN AI SANTORI E STAUDERMAN KA WHELAN K LLOYD GK MCDONALD IA

Citation: Ndp. Cosford et al., -(-)-5-ETHYNYL-3-(1-METHYL-2-PYRROLIDINYL)PYRIDINE MALEATE (SIB-1508Y) - A NOVEL ANTI-PARKINSONIAN AGENT WITH SELECTIVITY FOR NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS, Journal of medicinal chemistry, 39(17), 1996, pp. 3235-3237